In The Politics of Autism, I discuss evaluation, diagnosis, and the uncertainty of prevalence estimates.
An April 25 release from Autism Speaks:
This week, we proudly celebrate a historic expansion of the Autism and Developmental Disabilities Monitoring (ADDM) Network, from 11 to 16 sites across the country. The ADDM Network is the only collaborative network to track the number and characteristics of children with autism spectrum disorder (ASD) and other developmental disabilities in multiple communities throughout the United States. This is the first time since 2010 that the ADDM Network has added sites to its prevalence and surveillance work. The data and knowledge provided by the ADDM Network continues to inform and drive us forward in identifying gaps in diagnosis, improving screening tools and developing programs to reach underserved communities.
Autism Speaks has advocated in support of the CDC's autism activities for decades, through our advocacy for the Autism CARES Act, as well as supporting annual appropriations requests that have sustained and grown the level of funding for federal autism programs. It is thanks to our champions in Congress, the advocacy of Autism Speaks, partner organizations and countless advocates that spent years fighting for additional funding and successfully saw that the Consolidated Appropriations Act of 2023, enacted earlier this year, provided the Centers for Disease Control and Prevention (CDC) with support for the expansion of their work. As a result, the ADDM Network is now in its sixth phase of funding and includes fifteen funded sites and one CDC-managed site in Georgia (MADDSP).
The newly awarded sites include locations in Indiana, Pennsylvania, Texas (Austin) and Texas (Laredo) as well as Puerto Rico, marking the first time a US territory will be included in this research. Each ADDM site’s surveillance activities are different so that they collectively contribute to a fuller picture of what we know about autism. While every ADDM Network location will track ASD among 4- and 8-year-old children, nine sites will now also track transition planning and co-occurring conditions among 16-year-old children with ASD. This is almost a two-fold increase from five sites in previous years.